DGM007/iStock via Getty Images
Altimmune Inc. (NASDAQ:ALT) jumped 13% amid takeover speculation for the pharmaceutical firm.
There’s speculation that the developer of weight loss drugs is working on a strategic review with an adviser, according to traders, who cited a Betaville “uncooked” alert, which cited people following the matter.
